IYH: Healthcare Dashboard For September

A top-down analysis of the healthcare sector reveals that healthcare providers and pharmaceuticals/biotechnology subsectors are currently undervalued based on 11-year historical averages, with the latter also demonstrating a strong quality score. Healthcare equipment and life science tools, however, are near their historical baselines in terms of value and quality. For investors, the Health Care Select Sector SPDR ETF (XLV) is generally preferred over iShares U.S. Healthcare ETF (IYH) due to lower fees and superior historical performance, though both are highly concentrated, making Invesco S&P 500 Equal Weight Health Care ETF (RSPH) an option for more balanced exposure.

Analysis

A top-down quantitative analysis of the U.S. healthcare sector indicates that the pharmaceuticals/biotechnology and healthcare providers sub-sectors are currently undervalued relative to their 11-year historical metric averages. The pharmaceuticals/biotechnology group is particularly notable, as it combines this undervaluation with a strong quality score, and its value score has shown recent improvement. In contrast, the healthcare equipment and life science tools sub-sectors are trading near their historical valuation and quality baselines. When considering broad sector exposure via ETFs, the Health Care Select Sector SPDR ETF (XLV) is presented as a more compelling option than the iShares U.S. Healthcare ETF (IYH), based on XLV's significantly lower expense ratio (0.08% vs. 0.38%) and its 58 basis point annualized return outperformance since July 2000. A key risk for both funds is high concentration, with the top 10 holdings accounting for 56% of XLV's assets and 54.1% for IYH, making the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a suggested alternative for investors seeking to mitigate single-stock risk.

Key Decisions for Investors

• Investors seeking alpha within healthcare could consider overweighting the pharmaceuticals and biotechnology sub-sectors, given they are identified as both undervalued and high-quality based on the report's quantitative framework.
• For broad, market-cap-weighted exposure to the healthcare sector, the Health Care Select Sector SPDR ETF (XLV) is a more cost-effective and historically better-performing choice than the iShares U.S. Healthcare ETF (IYH).
• Due to the significant concentration risk in both XLV and IYH, investors should consider allocating a portion of their healthcare holdings to an equal-weight fund like the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) to achieve better diversification.
• Stock-picking investors can use the report's median metrics, such as targeting healthcare provider companies with an Earnings Yield above 0.0588, as a quantitative screen to identify potentially undervalued names within attractive sub-sectors.